The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
Company | Cost to borrow (% year) | Shares available | Country |
---|---|---|---|
Pfizer PFE | 0.4834% | 10 M | ๐บ๐ธ USA |
Eli Lilly LLY | 0.25% | 8.1 M | ๐บ๐ธ USA |
Amgen AMGN | 0.4081% | 4.7 M | ๐บ๐ธ USA |
Biogen BIIB | 0.2633% | 1.5 M | ๐บ๐ธ USA |
Gilead Sciences GILD | 0.4081% | 10 M | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 0.25% | 10 M | ๐บ๐ธ USA |
AstraZeneca AZN | 0.25% | 2.5 M | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | 0.2557% | 1.2 M | ๐ฌ๐ง UK |
Neurocrine Biosciences
NBIX | 0.3675% | 1.4 M | ๐บ๐ธ USA |